Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate...

Area of Science:

• Molecular Biology
• Biochemistry
• Cancer Research

Background:

• Protein arginine methyltransferases (PRMTs) are crucial for cellular processes like transcription and RNA processing.
• PRMT1 is a key enzyme in this family, with previously identified isoforms arising from alternative splicing.
• The full extent of PRMT1 isoform diversity and its functional implications remained largely unexplored.

Purpose of the Study:

• To investigate the complete repertoire of PRMT1 protein isoforms.
• To biochemically characterize the functional differences between PRMT1 variants.
• To determine the relevance of PRMT1 isoform balance in breast cancer.

Main Methods:

• Genomic analysis of the 5'-end of the PRMT1 gene to identify all potential transcription start sites.
• Biochemical characterization of purified PRMT1 isoforms, assessing catalytic activity and substrate specificity.
• Analysis of PRMT1 isoform expression levels in breast cancer samples.

Main Results:

• The PRMT1 gene can generate up to seven distinct protein isoforms, differing in their N-terminal domains.
• Unique N-terminal sequences significantly influence PRMT1's catalytic activity and substrate preference.
• A functional nuclear export sequence was identified in the PRMT1v2 isoform.
• The relative abundance of PRMT1 isoforms is significantly altered in breast cancer tissues.

Conclusions:

• PRMT1 exhibits greater isoform diversity than previously recognized, with N-terminal variations impacting enzymatic function.
• The discovery of a nuclear export sequence in PRMT1v2 adds another layer to its regulatory mechanisms.
• Altered PRMT1 isoform balance represents a potential hallmark of breast cancer, suggesting a role in tumorigenesis.